The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Estrogen and the prefrontal cortex: Towards a new understanding of estrogen's effects on executive functions in the menopause transition
Abstract
Midlife decline in cognition, specifically in areas of executive functioning, is a frequent concern for which menopausal women seek clinical intervention. The dependence of executive processes on prefrontal cortex function suggests estrogen effects on this brain region may be key in identifying the sources of this decline. Recent evidence from rodent, nonhuman primate, and human subject studies indicates the importance of considering interactions of estrogen with neurotransmitter systems, stress, genotype, and individual life events when determining the cognitive effects of menopause and estrogen therapy. Hum Brain Mapp 35:847–865, 2014. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In such a model, a decrease in estradiol levels during menopause could cause executive difficulties in women whose genetics or previous life experiences make them susceptible to such a cognitive decline (Culpepper, 2015; Kudielka et al, 2009; Shanmugan and Epperson, 2014) (Figure 1).”
From Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties (2017) · cites this paper as Shanmugan and Epperson, 2014
In the citing paper
“This midlife onset of executive difficulties may be a result of reduced estradiol modulation of the executive system (Shanmugan and Epperson, 2014).”
From Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties (2017) · cites this paper as Shanmugan and Epperson, 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Kudielka, B. M., Hellhammer, D. H., & Wüst, S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.004 · Cited by 963
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks
Arnsten, A. F. T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.027 · Cited by 493 · cited 4×
“DA and NE, the catecholamines crucial for executive functioning [Arnsten, 2011], are modulated by estrogen in the PFC. Treatment with 20 lg/kg of 17b-estradiol both improved memory consolidation and affected dopaminergic, noradrenergic, and serotonergic neurotransmission in the rodent PFC. Estrogen…”
BackgroundInfluentialOrbitofrontal cortex neurons: role in olfactory and visual association learning
Rolls, E. T., Critchley, H. D., Mason, R., & Wakeman, E. A. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.75.5.1970 · Cited by 398
Estrogen use, APOE, and cognitive decline: Evidence of gene–environment interaction
Yaffe, K., Haan, M., Byers, A., Tangen, C., & Kuller, L. (2000) · Neurology · doi:10.1212/wnl.54.10.1949 · Cited by 371
Caldeira, M. V., Melo, C. V., Pereira, D. B., Carvalho, R., Correia, S. S., Backos, D. S., Carvalho, A. L., Esteban, J. A., & Duarte, C. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700607200 · Cited by 251
Markham, J. A., Morris, J. R., & Juraska, J. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.015 · Cited by 230
The role of aromatization in testosterone supplementation: Effects on cognition in older men
Cherrier, M. M., Matsumoto, A. M., Amory, J. K., Ahmed, S., Bremner, W., Peskind, E. R., Raskind, M. A., Johnson, M., & Craft, S. (2005) · Neurology · doi:10.1212/01.wnl.0000149639.25136.ca · Cited by 226
Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction
Shansky, R. M., Glavis-Bloom, C., Lerman, D., McRae, P., Benson, C., Miller, K., Cosand, L., Horvath, T. L., & Arnsten, A. F. T. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001435 · Cited by 200 · cited 1×
“Similarly, lower does of FG7142, a benzodiazepine inverse agonist that triggers the stress response, were needed during proestrus than estrus to impair working memory function [Shansky et al., 2004].”
Background
Research works printed but not linked: 174
- 10.1177/1534582305277152 · DOI
- 10.1038/sj.npp.1301114 · DOI
- 10.1093/cercor/bhp214 · DOI
- 10.2165/00023210-200923000-00005 · DOI · Paper page
- 10.1159/000084872 · DOI
- 10.1016/S0896-6273(03)00597-X · DOI · Paper page
- 10.1016/j.neuroscience.2011.05.045 · DOI · Paper page
- 10.1016/S0028-3932(97)00072-9 · DOI
- 10.1523/JNEUROSCI.5289-06.2007 · DOI · Paper page
- 10.1016/j.biopsych.2012.03.032 · DOI
- Bayer U, 2011, Estrogen treatment affects brain functioning after menopause, Menopause Int, 17, 148, 10.1258/mi.2011.011105 · DOI
- 10.1016/j.neuroscience.2010.12.023 · DOI
- 10.1038/mp.2009.44 · DOI · Paper page
- Berent‐Spillson A, 2010, Early menopausal hormone use influences brain regions used for visual working memory, Menopause, 17, 692, 10.1097/gme.0b013e3181cc49e9 · DOI
- 10.1016/S0006-3223(99)00138-9 · DOI · Paper page
- 10.1016/j.psyneuen.2009.10.010 · DOI
- 10.1111/j.1365-2826.2008.01752.x · DOI
- 10.1016/S0079-6123(08)00925-4 · DOI
- 10.1016/S0306-4522(02)00156-2 · DOI · Paper page
- 10.1017/S0954579405050145 · DOI · Paper page
- Braudeau J, 2011, Chronic treatment with a promnesiant GABA‐A alpha5‐selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a down syndrome mouse model, Adv Pharmacol Sci, 2011, 153218
- 10.1006/nimg.1996.0247 · DOI · Paper page
- 10.1016/0166-4328(90)90167-D · DOI
- 10.3233/JAD-2004-6302 · DOI
- 10.1093/humupd/dmm020 · DOI
- 10.1126/science.165.3899.1271 · DOI
- 10.1016/j.mcn.2007.02.019 · DOI
- 10.1093/cercor/9.1.20 · DOI · Paper page
- 10.1152/jn.1997.77.2.761 · DOI
- 10.1016/S0006-3223(03)00236-1 · DOI
- 10.1016/j.brainres.2008.01.048 · DOI
- 10.1152/jn.1998.79.6.2919 · DOI
- 10.1007/s00221-001-0918-3 · DOI
- 10.1093/cercor/bhp048 · DOI
- 10.1101/lm.4.4.311 · DOI
- 10.1016/S0163-1047(05)80065-2 · DOI
- 10.1523/JNEUROSCI.23-25-08771.2003 · DOI · Paper page
- 10.1037/a0017734 · DOI
- 10.1002/(SICI)1097-0193(2000)9:1<42::AID-HBM5>3.0.CO;2-6 · DOI
- 10.1016/j.psyneuen.2011.04.010 · DOI
- 10.1016/j.yhbeh.2007.11.005 · DOI
- 10.1210/en.2005-0998 · DOI
- 10.1038/sj.npp.1301150 · DOI
- 10.1016/j.bbr.2010.02.004 · DOI
- 10.1016/S0926-6410(98)00004-4 · DOI
- 10.1046/j.0953-816X.2000.01323.x · DOI
- 10.1006/nimg.2000.0586 · DOI
- 10.1016/j.biopsycho.2009.10.009 · DOI
- 10.1073/pnas.0605569104 · DOI · Paper page
- 10.1006/hbeh.2000.1625 · DOI
- 10.1016/j.yhbeh.2007.09.011 · DOI
- 10.1016/j.yhbeh.2010.09.003 · DOI
- 10.1016/j.psyneuen.2004.09.002 · DOI
- 10.1523/JNEUROSCI.1202-10.2010 · DOI
- 10.1016/j.psyneuen.2011.07.007 · DOI
- 10.1016/j.biopsych.2012.07.018 · DOI
- 10.1097/gme.0b013e3181fcafd6 · DOI · Paper page
- 10.1016/j.neurobiolaging.2005.11.016 · DOI
- 10.1016/j.neurobiolaging.2004.11.009 · DOI
- Flores C, 1999, Ovariectomy of adult rats leads to increased expression of astrocytic basic fibroblast growth factor in the ventral tegmental area and in dopaminergic projection regions of the entorhinal and prefrontal cortex, J Neurosci, 19, 8665, 10.1523/JNEUROSCI.19-19-08665.1999 · DOI
- 10.1093/cercor/bhj143 · DOI · Paper page
- 10.1016/j.bbr.2008.02.008 · DOI · Paper page
- 10.1016/j.maturitas.2005.07.009 · DOI
- 10.1046/j.1532-5415.2003.51124.x · DOI
- 10.1093/cercor/10.6.535 · DOI
- 10.1016/S0166-4328(01)00255-8 · DOI
- 10.1016/j.neuroscience.2009.04.057 · DOI
- 10.1111/j.1460-9568.2006.04701.x · DOI
- 10.1016/j.neuroscience.2006.07.014 · DOI
- 10.1016/S0006-8993(97)01511-4 · DOI
- 10.1007/s00737-011-0230-6 · DOI
- 10.1016/j.neuroscience.2012.02.042 · DOI
- 10.1212/WNL.0b013e3181a71193 · DOI
- 10.1016/j.psyneuen.2006.05.004 · DOI
- 10.1210/en.2006-1626 · DOI
- 10.1016/0022-3956(95)00005-P · DOI
- Hallman DM, 1991, The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations, Am J Hum Genet, 49, 338
- 10.1073/pnas.0704757104 · DOI
- 10.1007/s11357-011-9278-5 · DOI
- 10.1007/s12311-011-0342-6 · DOI
- 10.1093/cercor/bhn241 · DOI
- 10.2217/WHE.10.87 · DOI
- 10.1016/j.neuroscience.2011.05.059 · DOI
- 10.1212/01.WNL.0000059413.75888.BE · DOI
- Hogervorst E, 2009, Brain and cognition. Is there any case for improving cognitive function in menopausal women using estrogen treatment, Minerva Ginecol, 61, 499
- 10.1016/j.maturitas.2010.02.005 · DOI
- 10.1016/j.yhbeh.2010.05.013 · DOI
- 10.1523/JNEUROSCI.6394-10.2011 · DOI · Paper page
- 10.1016/j.nlm.2010.08.016 · DOI
- 10.1097/01.gme.0000189618.48774.7b · DOI
- 10.1371/journal.pone.0030564 · DOI
- Kasai H, 2004, Structure‐stability‐function relationships of dendritic spines, Tanpakushitsu Kakusan Koso (Japan), 49, 276
- 10.1016/S0306-4530(01)00013-0 · DOI
- 10.1016/j.nlm.2004.10.003 · DOI
- 10.1016/j.neuron.2008.05.010 · DOI
- 10.1016/j.bbr.2011.10.047 · DOI
- 10.1016/j.fertnstert.2010.05.062 · DOI
- 10.1007/s00702-008-0073-0 · DOI
- 10.1002/(SICI)1096-9861(19990705)409:3<438::AID-CNE8>3.0.CO;2-5 · DOI
- 10.1002/(SICI)1096-9861(19980525)395:1<1::AID-CNE1>3.0.CO;2-4 · DOI
- 10.1016/j.psyneuen.2006.05.007 · DOI
- 10.1176/appi.ajp.160.8.1522 · DOI
- 10.1016/S0896-6273(00)80178-6 · DOI
- 10.1152/jn.2001.86.4.2001 · DOI
- 10.1002/jnr.21007 · DOI
- 10.1089/jwh.2006.0057 · DOI
- 10.1016/j.brainres.2006.07.016 · DOI
- 10.1196/annals.1347.012 · DOI
- 10.1016/j.brainres.2010.11.030 · DOI
- 10.1212/01.wnl.0000277275.42504.93 · DOI
- 10.1176/appi.ajp.158.2.227 · DOI
- 10.1016/j.expneurol.2005.09.008 · DOI
- Menzel HJ, 1984, Human apolipoprotein A‐I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Munster‐3 type, J Biol Chem, 259, 3070, 10.1016/S0021-9258(17)43261-3 · DOI
- 10.1016/S0028-3932(97)00027-4 · DOI
- 10.3109/13697137.2010.516848 · DOI
- 10.1007/s00213-001-0983-0 · DOI · Paper page
- 10.1016/S0006-3223(00)00967-7 · DOI
- 10.1001/archgenpsychiatry.2011.91 · DOI
- 10.3389/neuro.09.001.2008 · DOI
- 10.1124/jpet.108.147280 · DOI
- 10.1097/gme.0b013e3181e15df4 · DOI
- 10.4331/wjbc.v1.i5.133 · DOI
- 10.1016/j.neuron.2010.09.031 · DOI
- 10.3727/096368911X586765 · DOI
- 10.1016/j.psyneuen.2008.09.012 · DOI
- 10.1523/JNEUROSCI.15-01-00359.1995 · DOI
- 10.1016/j.neuroscience.2012.01.032 · DOI
- 10.1523/JNEUROSCI.23-13-05708.2003 · DOI
- 10.1212/01.wnl.0000339037.76336.cf · DOI
- 10.1210/jc.2005-2097 · DOI
- 10.1016/j.brainres.2010.10.031 · DOI · Paper page
- 10.2217/14622416.9.11.1589 · DOI
- 10.1523/JNEUROSCI.2631-10.2010 · DOI · Paper page
- 10.1523/JNEUROSCI.21-13-04801.2001 · DOI
- 10.1002/dneu.20641 · DOI
- 10.1152/jn.1994.71.2.515 · DOI
- 10.3109/13697130903009187 · DOI
- Schendzielorz N, 2011, Complex estrogenic regulation of catechol‐O‐methyltransferase (COMT) in rats, J Physiol Pharmacol, 62, 483
- 10.1111/j.1471-4159.2011.07423.x · DOI
- 10.1016/j.psyneuen.2008.09.017 · DOI
- 10.1186/1744-9081-2-8 · DOI · Paper page
- 10.1001/jama.281.13.1197 · DOI
- 10.1385/JMN:20:3:385 · DOI
- 10.1016/j.yfrne.2007.08.002 · DOI
- 10.1037/a0025539 · DOI
- 10.1097/AOG.0b013e3181d41191 · DOI
- 10.1016/S0006-3223(97)00437-X · DOI
- 10.1001/jama.289.20.2651 · DOI · Paper page
- 10.1016/j.neurobiolaging.2008.12.006 · DOI
- 10.1016/j.psyneuen.2010.08.002 · DOI
- 10.1210/jc.2006-0907 · DOI
- 10.1073/pnas.92.24.11110 · DOI
- 10.1016/j.psyneuen.2003.10.007 · DOI
- Srivastava RA, 1996, Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen, Biochem Mol Biol Int, 38, 91
- 10.1016/j.pscychresns.2005.04.004 · DOI
- 10.1016/S0014-4886(03)00215-2 · DOI
- 10.1093/cercor/bhg121 · DOI
- 10.1016/S0304-3940(97)00450-3 · DOI
- 10.1002/cne.11028 · DOI
- 10.1016/j.psyneuen.2009.04.014 · DOI
- 10.1523/JNEUROSCI.1591-09.2009 · DOI
- 10.1016/j.brainres.2006.07.064 · DOI
- 10.1523/JNEUROSCI.3192-10.2010 · DOI
- 10.1002/jnr.20076 · DOI
- 10.1111/j.1601-183X.2012.00764.x · DOI
- 10.1097/gme.0b013e318196a0c9 · DOI
- 10.1080/13825580600802893 · DOI
- 10.1016/j.bbr.2004.04.001 · DOI
- 10.1017/S1355617710001402 · DOI
- 10.1523/JNEUROSCI.5048-11.2012 · DOI · Paper page
- 10.1016/j.neuron.2011.12.033 · DOI · Paper page
- 10.1523/JNEUROSCI.17-21-08528.1997 · DOI · Paper page
- 10.1016/j.biopsych.2011.05.016 · DOI · Paper page
- 10.1016/j.neuropharm.2009.12.008 · DOI
Cited by
Sorted by citations
Sex and gender: modifiers of health, disease, and medicine
Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31561-0 · Cited by 2,001
Self-citationThe Brain on Stress: Vulnerability and Plasticity of the Prefrontal Cortex over the Life Course
McEwen, B. S., & Morrison, J. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.028 · Cited by 1,079
Sex differences and stress across the lifespan
Bale, T. L., & Epperson, C. N. (2015) · Nature Neuroscience · doi:10.1038/nn.4112 · Cited by 751
Self-citationSex Differences in Vulnerability and Resilience to Stress Across the Life Span
Hodes, G. E., & Epperson, C. N. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.028 · Cited by 417
Self-citationPeripheral and central mechanisms of stress resilience
Pfau, M. L., & Russo, S. J. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.09.004 · Cited by 170
Karalexi, M. A., Georgakis, M. K., Dimitriou, N. G., Vichos, T., Katsimpris, A., Petridou, E. T., & Papadopoulos, F. C. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104721 · Cited by 41
Female-specific pharmacotherapy in ADHD: Premenstrual adjustment of psychostimulant dosage
de Jong, M., Wynchank, D. S. M. R., van Andel, E., Beekman, A. T. F., & Kooij, J. J. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1306194 · Cited by 39
Aluminum-induced molecular neurodegeneration: The protective role of genistein and chickpea extract
Wahby, M. M., Mohammed, D. S., Newairy, A. A., Abdou, H. M., & Zaky, A. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.044 · Cited by 35
Shanmugan, S., Loughead, J., Nanga, R. P. R., Elliott, M., Hariharan, H., Appleby, D., Kim, D., Ruparel, K., Reddy, R., Brown, T. E., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.162 · Cited by 33
Self-citationADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives
Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211020 · Cited by 15
“Moreover, fluctuations in ovarian hormones influence dopaminergic and noradrenergic signaling, with clinical reports describing symptom worsening during low-estrogen phases and across reproductive transitions [137–140].”
de Jong, M., Wynchank, D. S. M. R., Michielsen, M., Beekman, A. T. F., & Kooij, J. J. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072106 · Cited by 11
Metadata
- Authors
- Shanmugan, S., & Epperson, C. N.
- Venue
- Human Brain Mapping
- Publisher
- Wiley
- Published
- 2012-12-14
- Volume
- 35
- Issue
- 3
- Pages
- 847-865
- ISSN
- 1065-9471
- 1097-0193
- PMC
- PMC4104582
- Cited by
- 173
- References
- 15
- Language
- en
- Funders
- National Institute of Mental Health and the Office of Research on Women's Health (Specialized Center of Research on Sex Differences in Women's Health) (P50MH099910)
- National Institute on Drug Abuse (K24DA03031)
- National Institute on Aging (R01AG030641)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
